Zoetis Inc (ZTS) Is Not Likely To Be The Same Tomorrow

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Zoetis Declares Second Quarter 2024 Dividend.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

As a NYSE listed company, ZTS falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $197.32 and fluctuated between $198.22 as its day high and $195.59 as its day low. The current market capitalization of Zoetis Inc is $90.59B. A total of 2.23 million shares were traded on the day, compared to an average of 1.25 shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, ZTS has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 923 shares. Over the last 12 months, there were 10 BUYs and 18 SELLs from insiders. Insiders purchased 45,327 shares during that period but sold 69,123.

In the most recent transaction, Lagano Roxanne sold 923 shares of ZTS for 191.43 per share on Jan 18. After the transaction, the Executive Vice President now owns 17,569 company shares. In a previous transaction on Dec 18, Lagano Roxanne sold 923 shares at 198.14 per share. ZTS shares that Executive Vice President owns now total 18,492.

Among the insiders who sold shares, Lagano Roxanne disposed of 2,500 shares on Dec 14 at a per-share price of $200.00. This resulted in the Executive Vice President holding 19,415 shares of ZTS after the transaction. In another insider transaction, PECK KRISTIN C sold 13,000 shares at $176.84 per share on Nov 21. Company shares held by the Chief Executive Officer now total 56,843.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Zoetis Inc pays an annual dividend of $1.48 (0.75%), resulting in a dividend yield of 1.56 (0.79%), and it has a price to earnings (P/E) ratio of 40.13. ZTS’s most recent ex-dividend date was 4/18/2024 when it declared a $0.4320 quarterly dividend that was paid in cash on 6/4/2024. Previously, the company paid the dividend on 3/1/2024 with an ex-dividend date of 1/18/2024. The ZTS stock dividend was $0.4320 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for ZTS in the last 3 months, the mean price target is $226.38 with high estimates of $255.00 and low estimates of $203.00. In terms of 52-week highs and lows, ZTS has a high of $201.92 and a low of $151.03.

As of this writing, ZTS has an earnings estimate of $1.32 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $1.35 per share and a lower estimate of $1.21. The company reported an EPS of $1.41 in the last quarter, which was 7.60% higher than expectations of $1.31.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ZTS’s latest balance sheet shows that the firm has $3.48B in Cash & Short Term Investments as of fiscal 2021. There were $6.74B in debt and $1.80B in liabilities at the time. Its Book Value Per Share was $11.05, while its Total Shareholder’s Equity was $4.54B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZTS is Buy with a score of 4.92.

Most Popular

Related Posts